Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Neurosteroids and enantiomers thereof for the prevention and treatment of neurodegenerative conditions

Neurosteroids and enantiomers thereof for the prevention and treatment of neurodegenerative conditions

US Patent 11497754 · Granted Nov 15, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Neuroactive 19-alkoxy-17-substituted steroids, prodrugs thereof, and methods of 2019
Neuroactive enantiomeric 15-, 16- and 17-substituted steroids as modulators for 2019
Neuroactive substituted cyclopent[a]anthracenes as modulators for GABA type-A re2018
Neuroactive 13, 17-substituted steroids as modulators for GABA type-A receptors2018
Neuroactive 19-alkoxy-17(20)-Z-vinylcyano-substituted steroids, prodrugs thereof2018
Neuroactive 19-alkoxy-17(20)-Z-vinylcyano-substituted steroids, prodrugs thereof2017
Neuroactive 19-alkoxy-17-substituted steroids, prodrugs thereof, and methods of 2017
Neuroactive 19-alkoxy-17-substituted steroids, prodrugs thereof, and methods of 2017
Neuroactive substituted cyclopent[a]anthracenes as modulators for GABA type-A re2017
Neuroactive 13, 17-substituted steroids as modulators for GABA type-A receptors2016
Neuroactive 17(20)-Z-vinylcyano-substituted steroids, prodrugs thereof, and meth2016
Neuroactive substituted cyclopenta[b]phenanthrenes as modulators for GABA type-A2016